Is there an optimal dose and formulation of aspirin to prevent arterial thrombo-embolism in man?

Bochner, F.; Lloyd, J.

doi:10.1042/cs0710625

Article navigation

Other| December 01 1986

Is there an optimal dose and formulation of aspirin to prevent arterial thrombo-embolism in man?

F. Bochner

Department of Clinical and Experimental Pharmacology, University of Adelaide, and Department of Clinical Pharmacology, Royal Adelaide Hospital, Adelaide, Australia

Search for other works by this author on:

This Site

PubMed

Google Scholar

;

J. Lloyd

Division of Haematology, Institute of Medical and Veterinary Science, Adelaide, Australia

Search for other works by this author on:

This Site

PubMed

Google Scholar

Clin Sci (Lond) (1986) 71 (6): 625–631.

https://doi.org/10.1042/cs0710625

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.

Portland Press
5th Floor, 90 High Holborn,
London WC1V 6LJ

Portland Press Tel
+44 (0)20 3880 2795
Biochemical Society Tel
+44 (0)20 3880 2793
Email: editorial@portlandpress.com

Privacy and cookies
Accessibility

Is there an optimal dose and formulation of aspirin to prevent arterial thrombo-embolism in man?

Article PDF first page preview

Cited By

Get Email Alerts

CONNECT

EXPLORE

Cover Image

Is there an optimal dose and formulation of aspirin to prevent arterial thrombo-embolism in man?

Article PDF first page preview

Sign in

Sign in to your personal account

Biochemical Society Member Sign in

Sign in via your Institution

Cited By

Get Email Alerts

Related Articles

CONNECT

EXPLORE

This Feature Is Available To Subscribers Only